FOXP3 and non-small cell lung carcinoma: Other studies have mainly paid close attention to the prognostic value of TIL subsets, such as CD3+, CD4+, CD8+, CD20+ and FoxP3+ lymphocyte subsets in the TN and/or TS of NSCLC.